St. Petersburg State Pavlov Medical University
Clinical trials sponsored by St. Petersburg State Pavlov Medical University, explained in plain language.
-
New drug cocktail aims to tame deadly transplant side effect
Disease control Recruiting nowThis phase 2 trial tests whether adding two drugs, ruxolitinib and abatacept, to standard transplant care can prevent graft-versus-host disease (GVHD) in 60 patients with high-risk myeloid cancers like AML and MDS. Participants receive a stem cell transplant from a partially matc…
Phase: PHASE2 • Sponsor: St. Petersburg State Pavlov Medical University • Aim: Disease control
Last updated Jun 22, 2026 11:56 UTC
-
New hope for hodgkin lymphoma: maintenance drug after transplant
Disease control Recruiting nowThis study tests whether a drug called a PD-1 inhibitor can help keep Hodgkin lymphoma from coming back after a stem cell transplant. It is for people whose lymphoma returned or did not respond to earlier treatments. About 83 adults will receive the drug as maintenance therapy an…
Phase: PHASE2 • Sponsor: St. Petersburg State Pavlov Medical University • Aim: Disease control
Last updated Jun 11, 2026 12:12 UTC
-
Immunotherapy combo shows promise in hodgkin lymphoma trial
Disease control Recruiting nowThis study compares two first-line treatments for advanced Hodgkin lymphoma. One group gets a new combination of the immunotherapy drug nivolumab plus chemotherapy (AVD), while the other group receives standard chemotherapy (BEACOPP-like). The goal is to see which approach is saf…
Phase: PHASE2 • Sponsor: St. Petersburg State Pavlov Medical University • Aim: Disease control
Last updated Jun 05, 2026 12:07 UTC